Diabetes News and Research

Latest Diabetes News and Research

Global health organizations join forces to raise awareness on dangers of fake medicines

Fake medicines increasingly put patients and the general public at risk across the world. In response to this challenge, ten partners who represent healthcare professionals, disease-specific organizations, product-development partnerships, foundations, international financing institutions, as well as the research-based pharmaceutical industry have joined forces to raise awareness about the dangers of fake medicines.

26 Nov 2013

Childhood exercise help mitigate obesity due to prenatal exposure to high-fat diets

Rats whose mothers were fed a high-fat diet during pregnancy and nursing were able to stave off some of the detrimental health effects of obesity by exercising during their adolescence, new Johns Hopkins research shows.

26 Nov 2013

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

The research of physician-scientist Katalin Susztak, MD, PhD, associate professor of Medicine in the Renal Electrolyte and Hypertension Division, at the Perelman School of Medicine, University of Pennsylvania, strives to understand the molecular roots and genetic predisposition of chronic kidney disease.

26 Nov 2013

New diabetes has little impact on outcomes in elderly hypertensives

Established, but not newly diagnosed, diabetes is associated with reduced survival among elderly patients with hypertension, shows an analysis of the ANBP2 study.

25 Nov 2013

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

Postmenopausal women who consumed sugar-sweetened beverages were more likely to develop the most common type of endometrial cancer compared with women who did not drink sugar-sweetened beverages, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

25 Nov 2013

BMI or measure of obesity does not play significant role in weight loss operation, says study

A new study investigating why obese patients choose one type of weight loss operation over another reveals that the main factors influencing decision making are whether patients have type 2 diabetes, how much weight they want to lose, and their tolerance for surgical risk to achieve their ideal weight.

25 Nov 2013

Researchers discover how type 2 diabetes drug metformin actually works

Researchers from St. Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with researchers at McMaster University in Canada, are reportedly the first to discover how the type 2 diabetes drug metformin actually works, providing a molecular understanding that could lead to the development of more effective therapies. Mass spectrometry technologies from AB SCIEX, a global leader in analytical technologies, played a critical role in the analysis that led to this breakthrough finding.

25 Nov 2013

Diabetes patients who receive medications by mail are less likely to visit emergency room

Patients with diabetes who received prescribed heart medications by mail were less likely to visit the emergency room than those patients who picked up prescriptions in person, according to a new Kaiser Permanente study published in the American Journal of Managed Care.

25 Nov 2013

CVD expert requests Mexican government to carry out mandatory screening for 18-year-olds

A cardiovascular disease expert is calling for mandatory screening of 18 year-old Mexicans to halt the CVD epidemic plaguing the nation. Cardiovascular risk factors will be a key theme at the Mexican Congress of Cardiology, held 23 to 27 November in Leon, Guanajuato, Mexico. The Congress is organised by the Mexican Society of Cardiology and features a collaborative programme with the European Society of Cardiology.

23 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

Vasculitis damage swift, accumulating

Study findings reveal the significant burden of disease among patients with antineutrophil-cytoplasm antibody associated vasculitis, with many individuals showing irreversible damage shortly after diagnosis.

22 Nov 2013

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

A new nanotechnology-based technique for regulating blood sugar in diabetics may give patients the ability to release insulin painlessly using a small ultrasound device, allowing them to go days between injections - rather than using needles to give themselves multiple insulin injections each day.

22 Nov 2013

Electronic health records may be used to measure patient-centeredness of primary care practices

Although electronic health records (EHR) are primarily used to store patient clinical data, the non-clinical data they collect may be used to measure patient-centeredness of primary care practices, finds a new study in Health Services Research. In addition, two of the process of care measures collected via EHRs, volume of between clinician e-messages and frequency of in-person patient visits, were associated with better patient health outcomes.

22 Nov 2013

Targeting single enzyme in the obese could help prevent and treat diabetes

A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once, according to mouse studies done by researchers at Columbia University Medical Center. The findings were published today in the online edition of Cell Metabolism.

22 Nov 2013

Frequent consumption of peanuts lowers risk of death

A major study published in the New England Journal of Medicine, showed that men and women who ate an ounce of peanuts daily reduced their risk of death from all causes by up to 20%. Results also showed that peanut eaters were leaner. This gives people another great reason to get their daily handful of peanuts.

22 Nov 2013

CKD children with lower socio-economic status less likely to grow to normal height ranges

Even with more prescriptions for growth hormone, children and adolescents with chronic kidney disease were less likely to grow to normal height ranges if they came from lower-income families, according to research funded by the National Institutes of Health. Results from the Chronic Kidney Disease in Children Study are published in the December issue of the American Journal of Kidney Diseases and online today at http://www.ajkd.org.

22 Nov 2013

High knowledge about HIV and risky sexual activity does not make teens more likely to get tested for HIV

Having high knowledge about HIV and engaging in risky sexual activity do not make high-school-aged teens more likely to get tested for HIV. Those are the findings of a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

22 Nov 2013

Brown fat stem cells may lead to new treatments for heart and endocrine disorders

Obesity and diabetes have become a global epidemic leading to severe cardiovascular disease. Researchers at the University of Utah believe their recent identification of brown fat stem cells in adult humans may lead to new treatments for heart and endocrine disorders, according to a new study published in the peer-reviewed journal Stem Cells.

22 Nov 2013

NYSCF partners with NIH to generate stem cell for treating rare diseases

In what is anticipated to be a major step forward for rare disease research, The New York Stem Cell Foundation (NYSCF) Research Institute is partnering with the National Institutes of Health (NIH) Undiagnosed Disease Program (UDP).

22 Nov 2013

Researchers identify a group of 39 genes linked with alcoholism

There is good evidence from studies of families and twins that genetics plays an important role in the development of alcoholism. However, hundreds of genes likely are involved in this complex disorder, with each variant contributing only a very small effect. Thus, identifying individual risk genes is difficult.

21 Nov 2013

Diabetes News and Research

Latest Diabetes News and Research

Global health organizations join forces to raise awareness on dangers of fake medicines

Childhood exercise help mitigate obesity due to prenatal exposure to high-fat diets

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

New diabetes has little impact on outcomes in elderly hypertensives

High intake of sugar-sweetened beverages reports increased risk of endometrial cancer

BMI or measure of obesity does not play significant role in weight loss operation, says study

Researchers discover how type 2 diabetes drug metformin actually works

Diabetes patients who receive medications by mail are less likely to visit emergency room

CVD expert requests Mexican government to carry out mandatory screening for 18-year-olds

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Vasculitis damage swift, accumulating

Nanotechnology-based technique: A painless method for maintaining healthy blood sugar levels

Electronic health records may be used to measure patient-centeredness of primary care practices

Targeting single enzyme in the obese could help prevent and treat diabetes

Frequent consumption of peanuts lowers risk of death

CKD children with lower socio-economic status less likely to grow to normal height ranges

High knowledge about HIV and risky sexual activity does not make teens more likely to get tested for HIV

Brown fat stem cells may lead to new treatments for heart and endocrine disorders

NYSCF partners with NIH to generate stem cell for treating rare diseases

Researchers identify a group of 39 genes linked with alcoholism

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in